|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 224 of 295 found articles
| Title: |
P-224: Pomalidomide, bortezomib, and dexamethasone after 1 prior line of therapy in relapsed or refractory multiple myeloma (RRMM): A safety subanalysis of the phase 3 OPTIMISMM trial |
| Author: |
Weisel, Katja Dimopoulos, Meletios-Athanasios Oriol, Albert Beksac, Meral Dimopoulos, Fredrik Liberati, Anna Marina Lindsay, Jindriska White, Darrell San-Miguel, Jesús F. Moreau, Philippe Anderson Jr, Larry D. Lorocca, Alessandra Robak, Pawef Vogel, Prisca Jiang, Ruiyun Grote, Lara Peluso, Teresa Richardson, Paul G. |
| Appeared in: |
Clinical lymphoma myeloma and leukemia |
| Paging: | Volume 21 () nr. S2 pages S163 |
| Year: |
2021 |
| Contents: | |
| Publisher: |
Elsevier Inc. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 224 of 295 found articles
| << previous | next >> |